Patent search ap:("Japan Tobacco Inc.") AND inv:"Takuya Machida" Page 1

1.

发明申请
TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF 有权

公开(公告)号：US20220162220A1

公开(公告)日：2022-05-26

申请号：US17493528

申请日：2021-10-04

Applicant: Japan Tobacco Inc.

Inventor： Masafumi Inoue , Yosuke Ogoshi , Takayuki Furukawa , Takuya Machida , Ikuo Mitani , Kazuhito Harada , Yuichi Nakagawa , Nobutaka YAMAOKA

IPC: C07D491/048

Abstract: The present invention provides a compound having a Pim-1 inhibitory activity.
The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.

2.

发明授权
Tetrahydrobenzofurodiazepinone compound and pharmaceutical use thereof 有权

公开(公告)号：US11643417B2

公开(公告)日：2023-05-09

申请号：US17493528

申请日：2021-10-04

Applicant: Japan Tobacco Inc.

Inventor： Masafumi Inoue , Yosuke Ogoshi , Takayuki Furukawa , Takuya Machida , Ikuo Mitani , Kazuhito Harada , Yuichi Nakagawa , Nobutaka Yamaoka

IPC: C07D491/048 , C07D491/107 , C07D519/00 , A61K31/551 , A61P9/12 , A61P11/00 , A61P17/06 , A61P35/00 , A61P43/00

CPC classification number: C07D491/048

Abstract: The present invention provides a compound having a Pim-1 inhibitory activity.
The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like.

wherein each symbol is as defined in the description.

3.

发明公开
TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF 审中-公开

公开(公告)号：US20240116943A1

公开(公告)日：2024-04-11

申请号：US18124389

申请日：2023-03-21

Applicant: Japan Tobacco Inc.

Inventor： Masafumi Inoue , Yosuke Ogoshi , Takayuki Furukawa , Takuya Machida , Ikuo Mitani , Kazuhito Harada , Yuichi Nakagawa , Nobutaka Yamaoka

IPC: C07D491/048

CPC classification number: C07D491/048

Abstract: The present invention provides a compound having a Pim-1 inhibitory activity.
The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like.

wherein each symbol is as defined in the description.

Patent Agency Ranking